BackSurrozen Overview

Surrozen Receivables

Track Surrozen's receivables ($5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$5.00M
↑ 94.63% YoYΔ $2.43M vs prior year quarter

Peer trimmed avg / median

Loading

Surrozen Receivables History

Loading

Surrozen vs. peers: Receivables Comparison

Loading

Surrozen Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Surrozen (SRZN) FAQ

Surrozen (SRZN) currently reports a receivables of $5M as of June 2026. That compares with $2.6M in the prior-year period — up 94.6% year over year. Use the charts on this page to explore Surrozen's receivables history and peer comparisons.

Surrozen's receivables increased from $2.6M to $5M — a 94.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Surrozen reported $5M in receivables as of June 2026. That compares with $2.6M in the prior-year period — up 94.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Surrozen, and consider following SRZN for alerts when major investors trade the stock.

Surrozen is classified in the Healthcare sector. On receivables, it currently shows $5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SRZN with unrelated industries.